C.D. Forbes

6.7k total citations · 1 hit paper
164 papers, 4.7k citations indexed

About

C.D. Forbes is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, C.D. Forbes has authored 164 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hematology, 51 papers in Pulmonary and Respiratory Medicine and 35 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in C.D. Forbes's work include Blood properties and coagulation (42 papers), Hemophilia Treatment and Research (25 papers) and Antiplatelet Therapy and Cardiovascular Diseases (25 papers). C.D. Forbes is often cited by papers focused on Blood properties and coagulation (42 papers), Hemophilia Treatment and Research (25 papers) and Antiplatelet Therapy and Cardiovascular Diseases (25 papers). C.D. Forbes collaborates with scholars based in United Kingdom, Netherlands and United States. C.D. Forbes's co-authors include C. R. M. Prentice, Gordon Lowe, Juhani Sivenius, Luı́s Cunha, Peer Smets, Hans‐Christoph Diener, J. J. F. Belch, C. Thomson, J.C. Barbenel and M. McLaren and has published in prestigious journals such as The Lancet, PLoS ONE and Biomaterials.

In The Last Decade

C.D. Forbes

156 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1996 1.0k citations Luı́s Cunha, C.D. Forbes et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.D. Forbes United Kingdom	32	1.5k	1.2k	1.0k	942	931	164	4.7k
J. Bonnar Ireland	43	997 0.7×	717 0.6×	1.5k 1.5×	613 0.7×	435 0.5×	193	6.0k
Edwin W. Salzman United States	40	2.4k 1.6×	1.1k 0.9×	1.3k 1.3×	2.0k 2.1×	409 0.4×	101	6.1k
John Fletcher Australia	33	485 0.3×	929 0.8×	418 0.4×	1.1k 1.2×	461 0.5×	193	4.5k
Gerd Häfner Germany	33	1.1k 0.7×	384 0.3×	725 0.7×	1.4k 1.5×	989 1.1×	76	5.3k
Moniek P.M. de Maat Netherlands	47	1.8k 1.2×	1.5k 1.3×	2.2k 2.1×	1.6k 1.7×	1.8k 1.9×	267	8.9k
W. Craig Hooper United States	43	1.2k 0.8×	358 0.3×	1.9k 1.9×	526 0.6×	634 0.7×	130	5.2k
Charles McCollum United Kingdom	54	2.8k 1.9×	3.2k 2.6×	654 0.6×	3.8k 4.0×	1.5k 1.6×	281	9.9k
Joseph Emmerich France	45	1.9k 1.3×	1.1k 0.9×	2.3k 2.2×	1.5k 1.6×	389 0.4×	221	7.4k
Bernd Stegmayr Sweden	42	950 0.6×	977 0.8×	473 0.5×	963 1.0×	982 1.1×	259	6.3k
Armin Grau Germany	37	963 0.7×	1.2k 1.0×	333 0.3×	475 0.5×	2.3k 2.5×	136	5.5k

Countries citing papers authored by C.D. Forbes

Since Specialization

Citations

This map shows the geographic impact of C.D. Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.D. Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.D. Forbes more than expected).

Fields of papers citing papers by C.D. Forbes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.D. Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.D. Forbes. The network helps show where C.D. Forbes may publish in the future.

Co-authorship network of co-authors of C.D. Forbes

This figure shows the co-authorship network connecting the top 25 collaborators of C.D. Forbes. A scholar is included among the top collaborators of C.D. Forbes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.D. Forbes. C.D. Forbes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Forbes, C.D., Stefan Nierkens, & Annelisa M. Cornel. (2024). Thymic NK-Cells and Their Potential in Cancer Immunotherapy. ImmunoTargets and Therapy. Volume 13. 183–194.

2.

Sivenius, Juhani, Luı́s Cunha, Hans-Christoph Diener, et al.. (2009). Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. Acta Neurologica Scandinavica. 99(1). 54–60. 12 indexed citations

3.

Sowden, Amanda & C.D. Forbes. (2001). On the evidence. Patient information.. PubMed. 111(5744). 36–7. 1 indexed citations

4.

Forbes, C.D.. (1998). Secondary Stroke Prevention with Low-Dose Aspirin, Sustained Release Dipyridamole Alone and in Combination. Thrombosis Research. 92(1). S1–S6. 34 indexed citations

5.

Madhok, Rajan, C.D. Forbes, & Bruce L. Evatt. (1994). Blood, blood products and HIV. 14 indexed citations

6.

Saniabadi, Abby R., Timothy S. Fisher, Chak Sing Lau, et al.. (1992). Dipyridamole increases human red blood cell deformability. European Journal of Clinical Pharmacology. 42(6). 651–4. 6 indexed citations

7.

Forbes, C.D., et al.. (1990). Effective Inhibition of Platelet Aggregation in Whole Blood with a Combination of Dipyridamole and Iloprost. Platelets. 1(3). 165–166. 1 indexed citations

8.

Marková, Ivana, Patricia Wilkie, S A Naji, & C.D. Forbes. (1990). Self- and other-awareness of the risk of HIV/AIDS in people with haemophilia and implications for behavioural change. Social Science & Medicine. 31(1). 73–79. 15 indexed citations

9.

Larkin, John G., et al.. (1988). Microvascular Disease and Limited Joint Mobility in Diabetes. A Comparison of Fibrinolysis and Prostacyclin in Diabetes and Systemic Sclerosis. Diabetic Medicine. 5(1). 53–56. 6 indexed citations

10.

McLaren, M., Ian A. Greer, James J. Walker, & C.D. Forbes. (1987). Reduced Prostacyclin Production by Umbilical Arteries from Pregnancy Complicated by Severe Pregnancy Induced Hypertension. 6(2). 365–374. 7 indexed citations

11.

Belch, J. J. F., et al.. (1987). Comparison of Inhibitory Actions of Prostacyclin and a New Prostacyclin Analogue on the Aggregation of Human Platelet in Whole Blood. Pathophysiology of Haemostasis and Thrombosis. 17(3). 147–153. 14 indexed citations

12.

Kluft, C, P. Cooper, A.F.H. Jie, et al.. (1985). Evaluation of Euglobulin Methods for the Study of Blood Fibrinolytic Activity: Results for Patients with Rheumatoid Arthritis and in the Postoperative Period. Pathophysiology of Haemostasis and Thrombosis. 15(2). 144–150. 4 indexed citations

13.

Forbes, C.D.. (1985). Hemostasis and Thrombosis. Journal of Clinical Pathology. 38(9). 1083.5–1084. 34 indexed citations

14.

Rose, Peter, N. McMillan, J. J. F. Belch, et al.. (1982). Haemophilia and the kidney: assessment after 11-year follow-up.. BMJ. 285(6355). 1609–1611. 24 indexed citations

15.

Forbes, C.D. & Ivana Marková. (1979). An international survey of genetic counselling in haemophilia.. PubMed. 6(2). 123–6. 6 indexed citations

16.

Forbes, C.D., et al.. (1976). Cost of management of patients with haemophilia.. BMJ. 2(6033). 465–467. 7 indexed citations

17.

Barrie, W W, et al.. (1974). Low-dosage Ancrod for Prevention of Thrombotic Complications after Surgery for Fractured Neck of Femur. BMJ. 4(5937). 130–133. 19 indexed citations

18.

Cb, Thompson, C.D. Forbes, Élisabeth Martin, & C. R. M. Prentice. (1973). Potentiation of Platelet Aggregation and Adhesion by Heparin Both in Vivo and in Vitro. Clinical Science. 44(4). 21P–21P. 9 indexed citations

19.

Forbes, C.D., G. P. McNicol, & A. S. Douglas. (1969). Action of a Pyrimido-pyrimidine Compound on Platelet Behaviour in Vitro. BMJ. 2(5655). 483–485. 12 indexed citations

20.

Turpie, A. G. G., C.D. Forbes, & G. P. McNicol. (1967). Idiopathic gangrene in African children.. BMJ. 3(5566). 646–648. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact